SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  December 2024 of Rs. 4478.30 millions grew by 23.56 % from Rs. 3624.30 millions.Net Profit of the company move down -32.34% to Rs. 468.90  millions from Rs. 693.00 millions  in the same quarter last year.Operating Profit saw a handsome growth to 931.40 millions from 292.60 millions in the quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 4478.30 3624.30 23.56 12744.58 10429.27 22.20 14421.68 10724.32 34.48
Other Income 189.30 99.40 90.44 347.84 233.46 48.99 303.86 418.48 -27.39
PBIDT 931.40 292.60 218.32 2136.93 436.65 389.39 813.05 -510.65 -259.22
Interest 28.90 23.60 22.46 60.92 86.55 -29.61 104.20 93.80 11.09
PBDT 902.50 949.10 -4.91 2076.01 1030.20 101.52 132.77 -1731.09 -107.67
Depreciation 284.50 256.10 11.09 809.47 802.33 0.89 1054.58 1059.79 -0.49
PBT 618.00 693.00 -10.82 1266.54 227.87 455.82 -921.81 -2790.88 -66.97
TAX 149.10 0.00 0.00 149.10 0.00 0.00 0.00 206.12 0.00
Deferred Tax 149.10 0.00 0.00 149.10 0.00 0.00 0.00 206.12 0.00
PAT 468.90 693.00 -32.34 1117.44 227.87 390.38 -921.81 -2997.00 -69.24
Equity 140.80 140.80 0.00 140.81 140.81 0.00 140.81 140.81 0.00
PBIDTM(%) 20.80 8.07 157.62 16.77 4.19 300.48 5.64 -4.76 -218.40

Unichem Lab Share Price

350.85 4.85 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×